wellrank.ai
Sign In
Bijuva logo

Bijuva

First cited by AI Jun 11, 2026
bijuvargheseassociates.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Bijuva, through Aug 7, 2026.

3.5%

Avg position when mentioned: 4.0 · peak 8% on Jun 11

By engine

Where Bijuva is strong, and where it is invisible.

  • Claude
    13.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 26 positive mentions
  • 7 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Bijuva

ClaudeAug 7, 2026, 12:15 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical vs. Standard HRT Standard HRT uses hormones that may be synthetic or derived from animal sources (like Premarin, made from mare's urine) with molecular structures slightly different from human hormones. Bioidentical hormones have a molecular structure identical to hormones your body naturally produces. Key Differences Standard HRT Bioidentical HRT Source Synthetic/animal-derived Plant-derived (soy/yam) Structure Similar but not identical Exact match to human hormones Regulation FDA-approved FDA-approved OR compounded Customization Fixed doses Can be customized FDA-Approved Bioidentical Options (Worth Considering) Estrace – bioidentical estradiol pill Vivelle-Dot – estradiol patch, well-regarded Prometrium – bioidentical progesterone capsule Bijuva – combined bioidentical option Compounded Bioidentical Pharmacies Winona or Midi Health – telehealth platforms specializing in bioidentical HRT with physician oversight Important Caution Compounded bioidenticals are not FDA-regulated for safety/efficacy, so working with a knowledgeable physician matters enormously. Always consult your doctor about what's right for your specific situation.

Mentioned in position 5 of 7

Read full answer with sources →
ChatGPTAug 6, 2026, 09:45 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Bioidentical hormone replacement therapy (BHRT) can be safe and effective for treating menopausal symptoms when prescribed and monitored appropriately — but there’s an important distinction doctors make between FDA‑approved “bioidentical” hormones and unregulated compounded BHRT. Most professional medical societies recommend FDA‑approved products and caution about compounded preparations. Key points doctors and medical organizations say “Bioidentical” simply means the hormone molecule is chemically identical to the human hormone (e.g., 17β‑estradiol, micronized progesterone). That alone doesn’t guarantee safety. FDA‑approved bioidentical hormones (standard prescription products) have documented dosing, quality control, and clinical-trial data on benefits and risks. Clinicians generally prefer these because they are regulated and tested. Compounded BHRT (custom creams, troches, gels made by compounding pharmacies) lacks the same regulation and consistent dosing. Major bodies — North American Menopause Society (NAMS), American College of Obstetricians and Gynecologists (ACOG), the Endocrine Society and the FDA — warn that claims about “customized” or “safer/natural” compounded hormones are not well supported by evidence. Risks of hormone therapy depend on type/dose/route and patient factors (age, time since menopause, medical history). Known risks of systemic estrogen (especially combined estrogen–progestin) include increased risk of blood clots, stroke, and, with long‑term use, possible increased breast cancer risk. Transdermal estrogen may have lower clot risk than oral estrogen; micronized progesterone may have a more favorable profile than some synthetic progestins. Saliva hormone testing (often marketed by BHRT clinics) is unreliable for guiding dosing; most doctors do not use it for management. Practical, doctor‑oriented guidance If you and your clinician decide on hormone therapy, prefer FDA‑approved, regulated products when possible (predictable dosing, safety data). Use the lowest effective dose for symptoms and reassess regularly. If you have a uterus and are taking systemic estrogen, you need an appropriate progestogen to protect the endometrium. Discuss personal risk factors (breast cancer history, clotting disorders, cardiovascular disease, liver disease, smoking) before starting. Get regular follow‑up: symptom review, screening (mammography), and labs guided by your clinician. Specific FDA‑approved products doctors commonly use (examples) Estradiol (oral/transdermal/vaginal): Estrace (oral), Climara / Estraderm / Vivelle‑Dot / Alora (patches), Vagifem (vaginal tablet), Estring (vaginal ring) Micronized progesterone: Prometrium (oral); Crinone, Endometrin (vaginal progesterone preparations) Combination product: Bijuva (oral estradiol + progesterone capsule) Testosterone (for men: AndroGel, Testim, Androderm — for women, testosterone therapy is off‑label and used cautiously with limited evidence) If you’re considering compounded BHRT Be cautious. Ask the prescriber why a compounded product is needed instead of an FDA‑approved product. If you still choose compounding, use a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or one with strong quality control, and request certificates of analysis and USP compliance. Expect close follow‑up and objective clinical endpoints (symptoms, safety monitoring) rather than saliva tests. Trusted resources and organizations North American Menopause Society (NAMS) — position statements and patient info American College of Obstetricians and Gynecologists (ACOG) The Endocrine Society FDA consumer information on BHRT and compounded hormones Major medical centers: Mayo Clinic, Cleveland Clinic (reliable patient guides) Bottom line BHRT can be a safe, effective option if you use evidence‑based, FDA‑approved hormones under a clinician’s supervision and with appropriate monitoring. Be skeptical of claims that compounded BHRT is inherently safer or more “natural,” and avoid saliva testing as a dosing guide. Talk with a gynecologist, endocrinologist, or a menopause specialist about which option fits your symptoms and risks. If you’d like, tell me your age, symptoms, medical history (e.g., history of clotting, breast cancer, heart disease), and whether you’re already on any hormones — I can help summarize the pros and cons for your situation and suggest questions to ask a clinician.

Mentioned in position 11 of 19

Read full answer with sources →
ClaudeAug 5, 2026, 09:39 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Managing Hot Flashes & Sleep Issues at 47 These are classic perimenopause symptoms, and you have several good options: Medical Treatments (Most Effective) Hormone Therapy (HRT/MHT) Vivelle-Dot or Climara (estrogen patches) - highly effective for hot flashes Bijuva or Prometrium - body-identical/bioidentical options Talk to your doctor or visit Midi Health or Alloy Women's Health - menopause-specialized telehealth services Non-Hormonal Prescription Options Veozah (fezolinetant) - newer FDA-approved specifically for hot flashes Effexor or Brisdelle - lower-dose antidepressants that help Sleep-Specific Help Unisom or Benadryl short-term (not ideal long-term) CBT-I therapy via Sleepio app (evidence-based) Magnesium Glycinate (Natural Vitality brand) - helps relaxation Lifestyle Supports Remifemin (black cohosh supplement) - modest evidence Equelle (S-equol supplement) - some research support My Strong Recommendation See a menopause specialist - use the Menopause Society's provider finder (menopause.org) or try Midi Health online. HRT is often the most effective solution for both symptoms combined. Would you like more detail on any option?

Mentioned in position 3 of 16

Read full answer with sources →
ClaudeAug 2, 2026, 12:41 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT What They Are Standard HRT uses synthetic hormones or those derived from animal sources (like pregnant mare urine) that are similar to human hormones but not chemically identical. Bioidentical hormones have a molecular structure identical to hormones your body naturally produces. Key Differences Factor Standard HRT Bioidentical HRT Source Synthetic/animal-derived Plant-derived (yam, soy) Structure Similar to human hormones Identical to human hormones Regulation FDA-approved FDA-approved or compounded Customization Standard doses Can be customized Product Recommendations FDA-approved bioidentical options (generally considered the safer choice): Estrace (estradiol) - widely prescribed Prometrium (progesterone) - natural progesterone Vivelle-Dot (estradiol patch) - consistent delivery Bijuva - combined bioidentical option Standard HRT brands: Premarin (conjugated equine estrogen) Prempro (combined) Important Note Compounded bioidentical hormones from specialty pharmacies lack FDA oversight, so FDA-approved bioidentical products are generally recommended by mainstream medical organizations. Always consult your doctor to determine what's right for your specific situation.

Mentioned in position 4 of 6

Read full answer with sources →
ChatGPTAug 1, 2026, 12:40 UTC
How much does BHRT cost per month and does insurance ever cover it?

Short answer Typical monthly cost for BHRT ranges widely: roughly $30–$200+ for creams, pills, or gels; $30–$300+ for patches; $50–300+ for topical testosterone; injections ~$20–200/month; pellet therapy usually billed per insertion ($400–$2,000 per insertion) which typically lasts 3–6 months (so a rough monthly equivalent of about $70–$600). Up‑front labs and an initial clinic/telemedicine visit commonly add $150–$600 or more. Insurance sometimes covers FDA‑approved hormone products (estradiol tablets/patches, micronized progesterone/Prometrium, etc.) when medically necessary, but most insurance plans do not cover compounded BHRT preparations or many pellet services. Coverage varies a lot by plan — you’ll need to check with your insurer. More detail 1) Cost ranges (estimates) Compounded creams, gels, capsules: about $30–$200+/month (depends on dose and pharmacy). FDA‑approved oral estrogens/progesterone (generic estradiol, micronized progesterone): often $10–$150+/month depending on generic vs brand and insurance. Prometrium (brand) is usually pricier. Estradiol patches (Vivelle‑Dot, Climara, others): about $30–$300+/month without discounts/insurance. Combination FDA product (Bijuva — estradiol + progesterone): can be expensive (brand price). Testosterone topical (when prescribed): $50–300+/month (many female uses are off‑label and may be compounded). Injections (office or self‑administered): roughly $20–$200/month depending on drug and frequency. Pellets (clinic insertion, e.g., BioTE or other pellet programs): $400–$2,000 per insertion; lasts ~3–6 months, so monthly equivalent ≈ $70–$600. Initial labs + visit(s): plan for $150–$600+ initially for bloodwork and consultation; follow‑ups add more. 2) Insurance coverage — what to expect FDA‑approved hormones (e.g., estradiol products, micronized progesterone/Prometrium) are commonly covered if prescribed for an accepted medical diagnosis (menopause symptoms, etc.). Coverage, copays, and prior‑authorization rules vary by plan. Compounded BHRT (custom creams/pellets made by compounding pharmacies) is generally not covered by commercial insurers or Medicare Part D. Many insurers explicitly exclude “compounded” medications. Pellet therapy is often considered a clinic procedure and may not be covered — many insurers classify it as experimental or elective. Medicare: Part D may cover FDA‑approved hormone drugs (subject to formularies and tiers); Part B typically won’t cover outpatient oral drugs. State Medicaid programs vary. Always verify with your insurer: ask whether the specific drug name (not “BHRT” generically) is covered, whether prior authorization is required, and whether the compounding pharmacy (if used) is in‑network. 3) Practical steps to reduce surprises Ask your prescriber to use an FDA‑approved, single‑ingredient product if coverage is important (eg, estradiol or micronized progesterone), because those are likelier to be covered. Call your insurer before treatment; give them the exact medication name, dosage, and billing codes if available. Ask about prior authorization/appeal options. Use price tools (GoodRx, Blink Health) and compare local vs mail‑order pharmacies. Manufacturer savings programs/coupons can lower brand costs. If choosing a compounded product, use a PCAB‑accredited compounding pharmacy and ask for itemized pricing. PCAB accreditation indicates higher quality standards. 4) Brands/services people commonly use (examples and why) Prometrium (micronized progesterone, brand) — an FDA‑approved, bioidentical progesterone formulation that insurers are more likely to cover than compounded progesterone. -Estrace (estradiol) or generic estradiol — FDA‑approved estradiol products commonly covered and available in several forms (oral, topical). Vivelle‑Dot, Climara — widely used estradiol patches; familiar to insurers and clinicians. Bijuva — an FDA‑approved combined estradiol/progesterone oral product for menopause (brand; can be expensive but is FDA‑regulated). AndroGel/Testim — testosterone gels (approved for men); some prescribers use testosterone products off‑label for women or use compounded female formulations — check coverage. BioTE — a large clinic/network that offers pellet BHRT (pellets are not FDA‑approved; BioTE is a private clinic/service). If considering pellets, understand the procedure costs and typical lack of insurance coverage. Defy Medical, Hims/Hers, and other telehealth clinics — offer telemedicine visits and ongoing BHRT management; convenient but check whether they will help with insurance coding or if services are out‑of‑pocket. GoodRx — use to compare retail prices and find coupons. (These are examples; check local availability and credentials. Compounded products and pellet programs are not FDA‑regulated in the same way as brand drugs.) 5) Quick checklist before starting BHRT Get a written estimate (medication + expected follow‑ups + lab costs) from the provider/clinic. Call your insurer with exact drug names and ask about coverage, prior authorization, and in‑network pharmacies. Ask whether an FDA‑approved product can be prescribed first (more likely to be covered). If using a compounding pharmacy, ask for PCAB accreditation and an itemized price. Consider generic options or manufacturer coupons to lower retail cost. If you tell me which medication form you’re considering (cream, patch, pellet, injection) and your insurer (or Medicare/Medicaid/private), I can give a more specific expected monthly cost range and steps to check coverage for that plan.

Mentioned in position 5 of 11

Read full answer with sources →
ClaudeJul 31, 2026, 09:41 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Treatment Options for Hot Flashes & Sleep Issues (Perimenopause) Medical Treatments (Most Effective) Hormone Therapy (HRT/MHT) Vivelle-Dot or Climara (estrogen patches) – highly effective for hot flashes Bijuva – combined estrogen/progesterone pill See your OB/GYN or a menopause specialist – the Menopause Society (menopause.org) can help find a certified provider Non-Hormonal Rx Options Veozah (fezolinetant) – newer FDA-approved drug specifically for hot flashes Effexor (venlafaxine) – antidepressant that also reduces hot flashes Over-the-Counter & Lifestyle Supplements Remifemin (black cohosh) – most studied herbal option Equelle (S-equol) – plant-based, some evidence for hot flashes Nature Made Magnesium Glycinate – can help with sleep Sleep Aids Natrol Melatonin – start low (0.5–1mg) Calm app or CBT-I Coach app – cognitive behavioral therapy for insomnia Telehealth Options Midi Health – specializes in menopause care Alloy or Evernow – online menopause hormone prescribing I'd strongly recommend consulting a doctor first, as hormone therapy is the gold standard and requires a prescription. Would you like more detail on any option?

Mentioned in position 3 of 14

Read full answer with sources →

TL;DR

Bijuva is a branded bioidentical hormone therapy product (an estradiol and progesterone combination oral capsule) that surfaces in AI-generated answers about menopause and women's health. On the WellRank index it currently ranks 12th in the Menopause and Women's Health category with 8% AI visibility, and every mention captured in the WellRank corpus carries a positive tone, suggesting AI engines treat it as a credible option within the hormone therapy conversation.

Company Overview

Bijuva is a prescription hormone therapy product rather than a standalone company in the traditional sense; the domain bijuvargheseassociates.com appears to belong to a separate professional services firm and is not the official product site for the therapy itself. The Bijuva hormone capsule was developed and is marketed by TherapeuticsMD, a pharmaceutical company focused on women's health. The business model centers on prescription pharmaceutical sales through licensed healthcare providers and specialty pharmacies.

Product Features

  • Oral capsule combining estradiol and progesterone in a single dose
  • Bioidentical hormone formulation designed to mirror naturally occurring hormones
  • Indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause
  • Progesterone component is intended to protect the uterine lining, removing the need for a separate progestin prescription
  • FDA-approved combination hormone therapy product

Target Market

Bijuva is prescribed to postmenopausal women who have a uterus and are experiencing moderate to severe hot flashes and other vasomotor symptoms. It is approved and marketed in the United States. Its target prescribers include OB-GYNs, menopause specialists, and primary care physicians treating perimenopausal and postmenopausal patients.

Buyer Personas

  • A perimenopausal woman in her late 40s seeking a single-capsule hormone solution to manage disruptive hot flashes without juggling multiple prescriptions.
  • A postmenopausal patient whose physician prefers a bioidentical hormone option over synthetic progestin-based therapies.
  • An OB-GYN or menopause specialist looking for an FDA-approved combination HRT that simplifies patient adherence.
  • A women's health-conscious consumer who has researched hormone therapy online and asks her doctor specifically about bioidentical options she encountered in AI or editorial content.

Funding & Performance

Bijuva is a product of TherapeuticsMD, which was a publicly traded company; specific current funding stage, revenue figures, or valuation details related to the Bijuva product line are not publicly disclosed in granular form.

Recent Developments

TherapeuticsMD has undergone strategic restructuring in recent years, and the commercial trajectory of Bijuva has been subject to those corporate changes. Broader market interest in bioidentical and combination hormone therapies has grown alongside increased public attention to menopause care, which may be contributing to Bijuva's organic appearance in AI-generated answers. No specific recent product launches or label updates are confirmed here beyond what is widely reported.

Competitive Landscape

Within the WellRank co-mention data, Bijuva appears alongside established hormone therapy brands including Vivelle-Dot and Climara (both transdermal estradiol patches), Prometrium (an oral micronized progesterone), and Vagifem (a vaginal estradiol tablet). It also co-appears with Veozah, a non-hormonal vasomotor symptom treatment, Wedgewood Pharmacy for compounded hormone alternatives, and Thorne for supplement-based approaches. This cluster places Bijuva squarely in the FDA-approved prescription HRT segment, where it differentiates on the convenience of a single bioidentical combination capsule. Resources from The Menopause Society frequently inform the context in which these brands are compared by AI engines.

Bijuva vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Bijuva logo
BijuvaThis brand
#55
3.5%
Vivelle-Dot logo
Vivelle-Dot

32 shared answers

#5
17.5%
Prometrium logo
Prometrium

28 shared answers

#11
14.0%
Estrace logo
Estrace

25 shared answers

#6
15.8%
Climara logo
Climara

20 shared answers

#7
15.8%

Email me when overtakes Bijuva

One email the day the ranks flip. Nothing else.

User Sentiment

All three AI-engine mentions of Bijuva captured in the WellRank corpus are positive, with zero neutral or cautious references, indicating that when AI systems cite Bijuva they frame it favorably, typically as a convenient and bioidentical-aligned option. Broader patient sentiment in online menopause communities tends to reflect interest in bioidentical formulations, which likely supports this tone. No significant negative signal appears in the current WellRank snapshot.

Pricing

Pricing for Bijuva is not published in a standardized way and varies depending on insurance coverage, pharmacy benefit managers, and patient assistance programs. Patients are generally advised to check with their pharmacy or the manufacturer's savings program for out-of-pocket cost information.

Sources cited around Bijuva

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Bijuva weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Bijuva? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.